The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., May. 26, 10:25 AM

Slide #2. Aldeyra Therapeutics, Inc. Secondary Offering

Company: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)
Date announced: 5/25/2016
Secondary Offering Details: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Aldeyra also expects to grant the underwriter a 30-day option to purchase additional shares of common stock offered in the public offering to cover over-allotments, if any. All of the shares in the offering are to be sold by Aldeyra, with net proceeds to be used for the continued development of NS2 and other product candidates, including further clinical testing of NS2, as well as for research and development activities, working capital and other general corporate purposes.

Aldeyra Therapeutics is a biotechnology company focused primarily on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. Co. is developing NS2, for the treatment of Sjogren-Larsson Syndrome and inflammatory diseases. NS2 is a small molecule designed specifically to trap and allow for the degradation of free aldehydes.
Open the ALDX Page at The Online Investor »

Company Name:  Aldeyra Therapeutics Inc
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding ALDX:  2
Total Market Value Held by ETFs:  $46350
Total Market Capitalization:  $50.00M
% of Market Cap. Held by ETFs:  0.09%

Open the ALDX Page at The Online Investor (in a new window) »

May 26, 2016    10:25 AM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
96th percentile
(ranked higher than approx. 96% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.